*Does Lymphaticovenous Anastomosis (LVA) Truly Improve Quality of Life?

— Evidence from the First Randomized Controlled Trial Comparing LVA with Conservative Therapy —**

 

【In-Depth Review of the Study】

To What Extent Can Lymphaticovenous Anastomosis (LVA) Improve the “Quality of Life” of Patients with Lymphedema?

 

【1. Why This Study Is Important】

Breast cancer–related lymphedema is a chronic condition that affects not only arm swelling, but also

pain, heaviness, restricted movement, and psychological stress,

leading to a long-term decline in patients’ quality of life (QOL).

 

The conventional standard treatment consists of conservative therapy (CDT), which combines:

・Compression garments

・Manual lymphatic drainage

・Exercise therapy and skin care

 

However, many patients have experienced:

・“The burden of lifelong treatment”

・“Difficulty balancing treatment with work and daily life”

On the other hand, lymphaticovenous anastomosis (LVA) is a surgical procedure that aims to improve symptoms by diverting lymphatic fluid into the venous system.

 

Previous studies on LVA, however, have faced several limitations, including:

・Small sample sizes

・A predominance of retrospective study designs

 

This study is particularly valuable because it directly compares LVA with conservative therapy using a randomized controlled trial (RCT)—the most reliable research design in clinical medicine.

 

【2. Study Design Explained in Plain Terms】

In this study, the participants were:

Patients with early to moderate upper-extremity lymphedema following breast cancer surgery

Patients in whom functional lymphatic vessels could be confirmed through imaging

 

These patients were randomly assigned to one of the following two groups:

▶ LVA Group

Conservative therapy was continued

Lymphaticovenous anastomosis was performed (1–5 anastomoses)

 

▶ Conservative Therapy Group (CDT Group)

No surgical intervention was performed

Standard conservative therapy was continued

Outcomes were evaluated at:

・3 months

・6 months

 

【3. The Most Important Outcome Measure: “Quality of Life (QOL)”】

The most distinctive feature of this study is that the primary outcome was not arm size, but rather

the quality of life as perceived by the patients themselves.

The study used the Lymph-ICF questionnaire, a globally validated and reliable assessment tool that comprehensively evaluates:

・Physical function

・Psychological burden

・Household activities

・Social participation

 

【4. Careful Interpretation of the Study Results】

① Improvement in Physical and Mental QOL

In the LVA group, statistically significant improvements were observed at 6 months in:

・Physical functioning

・Mental well-being

 

In particular, reductions were noted in symptoms such as:

・Arm heaviness

・Tightness

・Anxiety and stress

 

👉 This indicates that the daily burden and discomfort caused by lymphedema were alleviated.

 

 

【② Why Arm Volume Did Not Change Significantly】

At the same time, there was no clear difference in arm volume at the 6-month evaluation.

This does not mean that:

・“LVA is ineffective”

 

In lymphedema, structural tissue changes such as:

・Fat deposition

・Fibrosis

often progress over time. It is well recognized that changes in limb volume tend to occur later than improvements in quality of life.

 

 

【③ Many Patients Were Able to Reduce Compression Garment Use】

One particularly noteworthy finding was that approximately 40% of patients in the LVA group were able to partially or completely discontinue the use of compression garments.

For patients, this represents a meaningful reduction in the burden associated with:

・Work

・Household activities

・Travel

・Sleep

 

 

【5. Study Limitations and Appropriate Interpretation】

Although this is a high-quality study, the authors appropriately acknowledge several limitations:

・The observation period was limited to 6 months (long-term outcomes remain to be evaluated)

・LVA was performed only once (the impact of multiple procedures was not assessed)

・The same degree of benefit cannot be expected in all patients

 

👉 For these reasons, the study emphasizes the importance of:

・Appropriate patient selection

・Combining LVA with conservative therapy

 

 

【6. Alignment with the Treatment Philosophy of Lymphedema Clinic Tokyo】

At Lymphedema Clinic Tokyo, we:

・Place great importance on conservative therapy

・Carefully identify patients who may benefit from surgery

・Combine conservative treatment with day-surgery LVA at the appropriate timing

We believe this study is highly important because it demonstrates that this treatment strategy is supported by robust scientific evidence.

 

 

【7. Original Article】

Scientific Reports (2024)

The 6-month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer-related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy

DOI: https://doi.org/10.1038/s41598-024-52489-3

 

【8. Research Introduced by Our Clinic】

At our clinic, we carefully curate and introduce high-quality international research articles that are clinically relevant to lymphedema care.

▶ https://www.english-mominoki-shinryosho.net/research/

(Listed in the lower section of the page)

🇬🇧 English FAQ

Frequently Asked Questions About LVA and Quality of Life

 

 

Q1. What type of lymphedema patients were included in this study?

A.

This study focused on patients with early to moderate upper-extremity lymphedema following breast cancer treatment,

in whom functional lymphatic vessels could be confirmed by imaging.

It does not apply to all lymphedema patients.

 

 

Q2. Does LVA cure lymphedema?

A.

No. This study does not suggest a cure.

LVA is positioned as a treatment aimed at improving symptoms and quality of life (QOL) rather than achieving complete resolution.

 

 

Q3. What was the main outcome measured in this study?

A.

The primary outcome was patient-reported quality of life, not limb size.

This included physical, psychological, and daily functional aspects of living with lymphedema.

 

 

Q4. Will LVA always reduce arm size?

A.

Not necessarily.

At 6 months, the study did not show a significant difference in arm volume.

However, improvements in symptoms and daily comfort often precede measurable volume reduction.

 

 

Q5. How did quality of life improve after LVA?

A.

Patients in the LVA group experienced significant improvements in:

Arm heaviness

Tightness

Anxiety and stress

indicating a reduction in the daily burden of lymphedema.

 

 

Q6. Can patients stop wearing compression garments after LVA?

A.

Not all patients can discontinue compression garments.

However, in this study, approximately 40% of patients were able to partially or completely stop using them, which is a meaningful outcome for daily life.

 

 

Q7. Does LVA work equally well for all patients?

A.

No. The effectiveness of LVA may vary depending on:

Disease stage

Condition of the lymphatic vessels

Existing tissue changes

Careful patient selection is essential.

 

 

Q8. Are there limitations to this study?

A.

Yes. The authors note:

A follow-up period limited to 6 months

Only a single LVA procedure was evaluated

Long-term outcomes require further investigation.

 

 

Q9. How does Lymphedema Clinic Tokyo apply these findings in practice?

A.

At Lymphedema Clinic Tokyo, we emphasize:

Conservative therapy as the foundation

Thorough patient evaluation

Combining conservative care with appropriately timed day-surgery LVA when indicated

This study supports that approach with strong scientific evidence.

 

 

Q10. Can I read the original article myself?

A.

Yes. The article is open access and available to the public.

Scientific Reports (2024)

DOI: https://doi.org/10.1038/s41598-024-52489-3